FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs

U.S. Food and Drug Administration sent this bulletin at 03/28/2022 10:04 AM EDT

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs

Today the U.S. Food and Drug Administration approved the animal drug Firox, the first generic firocoxib chewable tablets indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs.

Firox Chewable Tablets contain the same active ingredient (firocoxib) in the same concentration and dosage form as the approved brand name drug product, Previcox, which was first approved on July 21, 2004. Firocoxib is a nonsteroidal anti-inflammatory drug (NSAID). Like many NSAIDs, firocoxib works by affecting certain enzymes that trigger pain, fever, and inflammation.

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.